Terms: = Lung cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL
768 results:
1. Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study.
Yang W; Fan X; Li W; Chen Y
Clin Respir J; 2024 May; 18(5):e13764. PubMed ID: 38685730
[TBL] [Abstract] [Full Text] [Related]
2. Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell lung cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence.
Moulson R; Law J; Sacher A; Liu G; Shepherd FA; Bradbury P; Eng L; Iczkovitz S; Abbie E; Elia-Pacitti J; Ewara EM; Mokriak V; Weiss J; Pettengell C; Leighl NB
Curr Oncol; 2024 Apr; 31(4):1947-1960. PubMed ID: 38668049
[TBL] [Abstract] [Full Text] [Related]
3. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
4. Prophylactic Cranial Irradiation in Limited-Stage Small Cell lung cancer: A Meta-Analysis.
Chi C; Wang C; Dong L; Li X; Xu L
J Coll Physicians Surg Pak; 2024 Apr; 34(4):461-467. PubMed ID: 38576291
[TBL] [Abstract] [Full Text] [Related]
5. Safety of lung resection surgery after severe acute respiratory syndrome coronavirus 2 infection in the post-vaccination era.
Im S; Na KJ; Park JH; Na B; Park S; Park IK; Kang CH; Kim YT
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38532301
[TBL] [Abstract] [Full Text] [Related]
6. An
Thor M; Lee C; Sun L; Patel P; Apte A; Grkovski M; Shepherd AF; Gelblum DY; Wu AJ; Simone CB; Chaft JE; Rimner A; Gomez DR; Deasy JO; Shaverdian N
J Nucl Med; 2024 Apr; 65(4):520-526. PubMed ID: 38485270
[TBL] [Abstract] [Full Text] [Related]
7. Combination tumor-treating fields treatment for patients with metastatic non-small cell lung cancer: A cost-effectiveness analysis.
Liu K; Zhu Y; Zhu H; Zeng M
Cancer Med; 2024 Mar; 13(5):e7070. PubMed ID: 38468503
[TBL] [Abstract] [Full Text] [Related]
8. Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors.
Hussain S; Mursal M; Verma G; Hasan SM; Khan MF
Eur J Pharmacol; 2024 May; 970():176484. PubMed ID: 38467235
[TBL] [Abstract] [Full Text] [Related]
9. Survival outcomes following complete mediastinal lymphadenectomy or selective mediastinal lymphadenectomy in patients with stage I-IIIA non-small cell lung cancer: protocol for a systematic review and meta-analysis.
Xu J; Lai J; Huang X; Ren Y; Chen Q; Li W
BMJ Open; 2024 Mar; 14(3):e084520. PubMed ID: 38458808
[TBL] [Abstract] [Full Text] [Related]
10. Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces.
Zheng X; Qiu L; Huang Y; Cheng R; Huang S; Xu K; Cai W; Deng Y; Wang W; Zhong X; Cui F; Hao Z; Liu J
Mol Immunol; 2024 Apr; 168():75-88. PubMed ID: 38430689
[TBL] [Abstract] [Full Text] [Related]
11. DARDN: A Deep-Learning Approach for CTCF Binding Sequence Classification and Oncogenic Regulatory Feature Discovery.
Cho HJ; Wang Z; Cong Y; Bekiranov S; Zhang A; Zang C
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397134
[TBL] [Abstract] [Full Text] [Related]
12. Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging.
Stoevesandt D; Ludwig C; Mauz-Körholz C; Körholz D; Hasenclever D; McCarten K; Flerlage JE; Kurch L; Wohlgemuth WA; Landman-Parker J; Wallace WH; Fosså A; Vordermark D; Karlén J; Cepelová M; Klekawka T; Attarbaschi A; Hraskova A; Uyttebroeck A; Beishuizen A; Dieckmann K; Leblanc T; Daw S; Steglich J
Pediatr Radiol; 2024 May; 54(5):725-736. PubMed ID: 38296856
[TBL] [Abstract] [Full Text] [Related]
13. Elevated enteric putrescine suppresses differentiation of intestinal germinal center B cells.
Wei X; Shi S; Lu Z; Li C; Xu X; Chai J; Liu X; Hu T; Wang B
Int Immunopharmacol; 2024 Feb; 128():111544. PubMed ID: 38266445
[TBL] [Abstract] [Full Text] [Related]
14. Arsenic in drinking water and lung cancer: A systematic review of 35 years of evidence.
Issanov A; Adewusi B; Saint-Jacques N; Dummer TJB
Toxicol Appl Pharmacol; 2024 Feb; 483():116808. PubMed ID: 38218206
[TBL] [Abstract] [Full Text] [Related]
15. Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma.
Zupanc C; Franko A; Štrbac D; Kovač V; Dolžan V; Goričar K
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203360
[TBL] [Abstract] [Full Text] [Related]
16. Ct-based subregional radiomics using hand-crafted and deep learning features for prediction of therapeutic response to anti-PD1 therapy in NSCLC.
Hu Y; Jiang T; Wang H; Song J; Yang Z; Wang Y; Su J; Jin M; Chang S; Deng K; Jiang W
Phys Med; 2024 Jan; 117():103200. PubMed ID: 38160516
[TBL] [Abstract] [Full Text] [Related]
17. Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysis.
Shimizu T; Inoue E; Ohkuma R; Kobayashi S; Tsunoda T; Wada S
Front Immunol; 2023; 14():1308381. PubMed ID: 38115995
[TBL] [Abstract] [Full Text] [Related]
18. ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia.
Chen J; Sathiaseelan V; Reddy Chilamakuri CS; Roamio Franklin VN; Jakwerth CA; D'Santos C; Ringshausen I
Blood Adv; 2024 Mar; 8(5):1167-1178. PubMed ID: 38113463
[TBL] [Abstract] [Full Text] [Related]
19. Mendelian randomization suggests a causal relationship between gut dysbiosis and thyroid cancer.
Zhu F; Zhang P; Liu Y; Bao C; Qian D; Ma C; Li H; Yu T
Front Cell Infect Microbiol; 2023; 13():1298443. PubMed ID: 38106470
[TBL] [Abstract] [Full Text] [Related]
20. JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers.
Lu X; Yu R; Li Z; Yang M; Dai J; Liu M
Cancer Lett; 2024 Feb; 582():216517. PubMed ID: 38101609
[TBL] [Abstract] [Full Text] [Related]
[Next]
